​

Funding Round

Series B - Valitor

Series B - Valitor

Investment Firm

Overview

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

Announced Date

Oct 05, 2022

Closed on Date

Oct 06, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Morningside Venture Investments

Morningside Venture Investments

Morningside Venture Investments is a private_equity and venture firm.

Participant Investors

4

Investor Name
Participant InvestorMorningside Venture Investments
Participant InvestorFirst Spark Ventures
Participant InvestorExSight Ventures
Participant InvestorPandect Bioventures

Round Details and Background

Valitor raised $28000000 on 2022-10-05 in Series B

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 20, 2018
Series A - Valitor
8-2.5M
Jan 11, 2022
Venture Round - Valitor
-8.4M
Oct 05, 2022
Series B - Valitor
5-28.0M
Dec 01, 2015
Non Equity Assistance - Valitor
1-undefined

Recent Activity

There is no recent news or activity for this profile.